How Soft Tissue Sarcoma Metastasizes
Soft tissue sarcomas metastasize predominantly through hematogenous (bloodborne) spread to the lungs, with lymphatic spread being uncommon except in specific histologic subtypes. 1
Primary Metastatic Pattern: Hematogenous Spread
The dominant route of metastasis is through the bloodstream, with the lungs being the most common site of distant metastasis 1, 2. This hematogenous pattern typically occurs within 2-3 years after completion of primary therapy 2. The 2025 UK guidelines explicitly state that "soft-tissue sarcomas have a predominant pattern of metastases to the lungs" 1, which is why chest CT is the cornerstone of staging for most STS patients.
Secondary Hematogenous Sites
Beyond the lungs, other organs affected by bloodborne spread include:
- Bone: Approximately 2.2% of patients present with skeletal metastasis at diagnosis, though up to 10% develop bone metastases after a mean interval of 21.3 months 3, 4
- Liver and peritoneum: More common in abdominal/retroperitoneal sarcomas 5
- Brain: Particularly in alveolar soft part sarcoma, clear cell sarcoma, and angiosarcoma 1, 6
- Soft tissues: Especially in myxoid liposarcoma, which has unusual patterns of soft tissue metastases 1
Lymphatic Spread: The Exception, Not the Rule
Lymphatic dissemination is rare in most soft tissue sarcomas, occurring in less than 1% of cases 7. However, specific histologic subtypes demonstrate significantly higher rates of regional lymph node involvement and require dedicated nodal staging 1, 6:
High-Risk Subtypes for Lymphatic Spread:
- Synovial sarcoma (80% when metastatic) 8
- Clear cell sarcoma
- Epithelioid sarcoma (100% when metastatic) 8
- Angiosarcoma
- Rhabdomyosarcoma (100% when metastatic) 8
For these subtypes, the 2025 UK guidelines specifically recommend "regional lymph node assessment, by ultrasound or cross-sectional imaging" 1.
Histology-Specific Metastatic Patterns
Different sarcoma subtypes exhibit distinct metastatic behaviors:
- Myxoid liposarcoma: Unusual propensity for soft tissue metastases and bone involvement, requiring abdominal/pelvic CT or whole-body MRI 1, 6
- Leiomyosarcoma: Higher risk of liver metastases, warranting abdominal imaging 1
- Alveolar soft part sarcoma: Increased incidence of brain metastases 1, 6
- High-grade extremity sarcomas: Require comprehensive staging including abdomen/pelvis 1
Risk Factors for Metastatic Spread
The likelihood of metastasis correlates strongly with:
- Tumor grade: High-grade tumors have substantially higher metastatic potential 4
- Tumor depth: Deep tumors (below fascia) have 5-12-fold increased tendency for metastasis 4
- Tumor size: Larger tumors (>5 cm) carry higher risk
- Regional lymph node involvement: When present, increases risk of bone metastasis 4.5-fold (OR = 4.48) 4
Clinical Implications for Staging
Based on these metastatic patterns, the 2025 UK guidelines establish a clear staging algorithm 1:
Standard staging for all intermediate/high-grade STS:
- CT chest (mandatory for pulmonary metastases)
- Consider abdomen/pelvis CT for myxoid liposarcoma, leiomyosarcoma, and high-grade lower extremity sarcomas
Histology-specific additions:
- Brain imaging (CT or MRI) for alveolar soft part sarcoma, clear cell sarcoma, angiosarcoma
- Regional nodal assessment for synovial sarcoma, clear cell sarcoma, epithelioid sarcoma, angiosarcoma
- Whole-body MRI as alternative for myxoid liposarcoma
Low-risk subtypes (atypical lipomatous tumors, dermatofibrosarcoma protuberans) may require only chest X-ray given negligible metastatic risk 1.
Temporal Sequence
The timing of lymphatic versus hematogenous spread varies by histology. In osteosarcoma, lymphatic dissemination is always preceded by hematogenous spread, while in synovial sarcoma, rhabdomyosarcoma, and neurogenic sarcoma, lymphatic spread more frequently occurs before bloodborne metastases 8. This underscores the importance of histology-specific surveillance strategies.